Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine- N -Oxide

ABSTRACT Choline is a water-soluble nutrient essential for human life. Gut microbial metabolism of choline results in the production of trimethylamine (TMA), which upon absorption by the host is converted in the liver to trimethylamine-N-oxide (TMAO). Recent studies revealed that TMAO exacerbates atherosclerosis in mice and positively correlates with the severity of this disease in humans. However, which microbes contribute to TMA production in the human gut, the extent to which host factors (e.g., genotype) and diet affect TMA production and colonization of these microbes, and the effects TMA-producing microbes have on the bioavailability of dietary choline remain largely unknown. We screened a collection of 79 sequenced human intestinal isolates encompassing the major phyla found in the human gut and identified nine strains capable of producing TMA from choline in vitro. Gnotobiotic mouse studies showed that TMAO accumulates in the serum of animals colonized with TMA-producing species, but not in the serum of animals colonized with intestinal isolates that do not generate TMA from choline in vitro. Remarkably, low levels of colonization by TMA-producing bacteria significantly reduced choline levels available to the host. This effect was more pronounced as the abundance of TMA-producing bacteria increased. Our findings provide a framework for designing strategies aimed at changing the representation or activity of TMA-producing bacteria in the human gut and suggest that the TMA-producing status of the gut microbiota should be considered when making recommendations about choline intake requirements for humans. IMPORTANCE Cardiovascular disease (CVD) is the leading cause of death and disability worldwide, and increased trimethylamine N-oxide (TMAO) levels have been causally linked with CVD development. This work identifies members of the human gut microbiota responsible for both the accumulation of trimethylamine (TMA), the precursor of the proatherogenic compound TMAO, and subsequent decreased choline bioavailability to the host. Understanding how to manipulate the representation and function of choline-consuming, TMA-producing species in the intestinal microbiota could potentially lead to novel means for preventing or treating atherosclerosis and choline deficiency-associated diseases.

Abstract licence: CC BY

• Beyond the gut: decoding the gut–immune–brain axis in health and disease · 2025

• Drug-microbiota interactions: an emerging priority for precision medicine · 2023

• Corrected

  Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis · 2022

• The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke · 2022

• Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome · 2021

• Gut microbiome variation modulates the effects of dietary fiber on host metabolism · 2021

• Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice · 2021

• Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide · 2020

• The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases · 2020

• The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases · 2020

• Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis · 2020

• The Role of Oral Microbiota in Intra-Oral Halitosis · 2020

• Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health · 2019

• Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health · 2019

• Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target · 2019

• Microbial impact on cholesterol and bile acid metabolism: current status and future prospects · 2019

• A Prospective Metagenomic and Metabolomic Analysis of the Impact of Exercise and/or Whey Protein Supplementation on the Gut Microbiome of Sedentary Adults · 2018

• Dietary Choline Intake: Current State of Knowledge Across the Life Cycle · 2018

• Trimethylamine‐ N ‐oxide promotes brain aging and cognitive impairment in mice · 2018

• Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function · 2018

and 9 more

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.